Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
Fireside chat with Chairman & CEO Lishan Aklog, M.D., scheduled for Friday, September 5, at 8:35 AM EDT Lucid Diagnostics Inc.(Nasdaq: LUCD)(“Lucid” or the “Company”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM)(“PAVmed”), today announced Lishan Aklog, M.D., Lucid's Chairman and Chief Executive Officer will participate in a fireside […]